Recent advances of genomic testing in perinatal medicine

Seminars in Perinatology

Volumn 39, Issue 1, 2015, Pages 44-54

  Peters, David G ^a,b   Yatsenko, Svetlana A ^a   Surti, Urvashi ^a,b,c   Rajkovic, Aleksandar ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ARTICLE; CHROMOSOME ANALYSIS; CONGENITAL MALFORMATION; EXOME; FLUORESCENCE IN SITU HYBRIDIZATION; GENE SEQUENCE; GENETIC DISORDER; GENOME ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MICROARRAY ANALYSIS; PERINATAL CARE; PERINATAL MORBIDITY; PRENATAL DIAGNOSIS; ANEUPLOIDY; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; PREGNANCY; PROCEDURES; REPRODUCTION; TRENDS;

ANEUPLOIDY; FEMALE; GENETIC COUNSELING; GENETIC TESTING; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PREGNANCY; PRENATAL DIAGNOSIS; REPRODUCTIVE MEDICINE;

EID: 84916229203     PISSN: 01460005     EISSN: 1558075X     Source Type: Journal    
DOI: 10.1053/j.semperi.2014.10.009     Document Type: Article

References (65)

1. MacDorman M.F., Kirmeyer S. Fetal and perinatal mortality, United States, 2005. Natl Vital Stat Rep 2009, 57(8):1-19.
2. Carvalho C.M., Zhang F., Lupski J.R. Evolution in health and medicine Sackler colloquium: genomic disorders: a window into human gene and genome evolution. Proc Natl Acad Sci U S A 2010, 107(suppl 1):1765-1771.
3. Schwartz S. Clinical utility of single nucleotide polymorphism arrays. Clin Lab Med 2011, 31(4):581-594.
4. Manning M., Hudgins L., Professional Practice and Guidelines Committee Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010, 12(11):742-745.
5. Miller D.T., Adam M.P., Aradhya S., et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010, 86(5):749-764.
6. Hochstenbach R., van Binsbergen E., Engelen J., et al. Array analysis and karyotyping: workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the Netherlands. Eur J Med Genet 2009, 52(4):161-169.
7. Reddy U.M., Page G.P., Saade G.R., et al. Karyotype versus microarray testing for genetic abnormalities after stillbirth. N Engl J Med 2012, 367(23):2185-2193.
8. Schaeffer A.J., Chung J., Heretis K., Wong A., Ledbetter D.H., Lese Martin C. Comparative genomic hybridization-array analysis enhances the detection of aneuploidies and submicroscopic imbalances in spontaneous miscarriages. Am J Hum Genet 2004, 74(6):1168-1174.
9. Hillman S.C., Pretlove S., Coomarasamy A., et al. Additional information from array comparative genomic hybridization technology over conventional karyotyping in prenatal diagnosis: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2011, 37(1):6-14.
10. Raca G., Artzer A., Thorson L., et al. Array-based comparative genomic hybridization (aCGH) in the genetic evaluation of stillbirth. Am J Med Genet A 2009, 149A(11):2437-2443.
11. Shaffer L.G., Dabell M.P., Fisher A.J., et al. Experience with microarray-based comparative genomic hybridization for prenatal diagnosis in over 5000 pregnancies. Prenat Diagn 2012, 32(10):976-985.
12. Yatsenko S.A., Davis S., Hendrix N.W., et al. Application of chromosomal microarray in the evaluation of abnormal prenatal findings. Clin Genet 2013, 84(1):47-54.
13. Wapner R.J., Martin C.L., Levy B., et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med 2012, 367(23):2175-2184.
14. Malone F.D., Canick J.A., Ball R.H., et al. First-trimester or second-trimester screening, or both, for Down[U+05F3]s syndrome. N Engl J Med 2005, 353(19):2001-2011.
15. Mujezinovic F., Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007, 110(3):687-694.
16. Tabor A., Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 2010, 27:1-7.
17. Tabor A., Philip J., Madsen M., Bang J., Obel E.B., Nørgaard-Pedersen B. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986, 1(1):1287-1293.
18. Odibo A.O., Gray D.L., Dicke J.M., Stamilio D.M., Macones G.A., Crane J.P. Revisiting the fetal loss rate after second-trimester genetic amniocentesis: a single center[U+05F3]s 16-year experience. Obstet Gynecol 2008, 111(3):589-595.
19. Hewison J., Nixon J., Fountain J., et al. A randomised trial of two methods of issuing prenatal test results: the ARIA (amniocentesis results: investigation of anxiety) trial. BJOG 2007, 114(4):462-468.
20. Hewison J., Nixon J., Fountain J., et al. Amniocentesis results: investigation of anxiety. The ARIA trial. Health Technol Assess 2006, 10(50). iii, ix-x 1-78.
21. Hertling-Schaal E., Perrotin F., de Poncheville L., Lansac J., Body G. Maternal anxiety induced by prenatal diagnostic techniques: detection and management. Gynecol Obstet Fertil 2001, 29(6):440-446.
22. Boyer S.H., Noyes A.N., Boyer M.L. Enrichment of erythrocytes of fetal origin from adult-fetal blood mixtures via selective hemolysis of adult blood cells: an aid to antenatal diagnosis of hemoglobinopathies. Blood 1976, 47(6):883-897.
23. Iverson G.M., Bianchi D.W., Cann H.M., Herzenberg L.A. Detection and isolation of fetal cells from maternal blood using the fluorescence-activated cell sorter (FACS). Prenat Diagn 1981, 1(1):61-73.
24. Bianchi D.W., Simpson J.L., Jackson L.G., et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat Diagn 2002, 22(7):609-615.
25. Huang R., Barber T.A., Schmidt M.A., et al. A microfluidics approach for the isolation of nucleated red blood cells (NRBCs) from the peripheral blood of pregnant women. Prenat Diagn 2008, 28(10):892-899.
26. Zimmermann S., Hollmann C., Stachelhaus S.A. Unique monoclonal antibodies specifically bind surface structures on human fetal erythroid blood cells. Exp Cell Res 2013, 319(17):2700-2707.
27. Mouawia H., Saker A., Jais J.P., et al. Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy. Reprod Biomed Online 2012, 25(5):508-520.
28. Mandel P., Metais P. Les acides nucleiques du plasma sanguin chez l[U+05F3]homme. C R Acad Sci Paris 1948, 142(3-4):241-243.
29. Lo Y.M., Corbetta N., Chamberlain P.F., et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350(9076):485-487.
30. Lo Y.M., Tein M.S., Lau T.K., et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998, 62(4):768-775.
31. Lo Y.M., Zhang J., Leung T.N., Lau T.K., Chang A.M., Hjelm N.M. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999, 64(1):218-224.
32. Chiu R.W., Chan C.W., Zhong X.Y., et al. Fetal rhesus D mRNA is not detectable in maternal plasma. Clin Chem 2005, 51(11):2210-2211.
33. Lo Y.M. Fetal DNA in maternal plasma: biology and diagnostic applications. Clin Chem 2000, 46(12):1903-1906.
34. Lo Y.M. Fetal RhD genotyping from maternal plasma. Ann Med 1999, 31(5):308-312.
35. Li Y., Holzgreve W., Naro E D.I., Vitucci A., Hahn S. Cell-free DNA in maternal plasma: is it all a question of size?. Ann N Y Acad Sci 2006, 1075:81-87.
36. Li Y., Page-Christiaens G.C., Gille J.J., Holzgreve W., Hahn S. Non-invasive prenatal detection of achondroplasia in size-fractionated cell-free DNA by MALDI-TOF MS assay. Prenat Diagn 2007, 27(1):11-17.
37. Li Y., Di Naro E., Vitucci A., Zimmermann B., Holzgreve W., Hahn S. Detection of paternally inherited fetal point mutations for beta-thalassemia using size-fractionated cell-free DNA in maternal plasma. J Am Med Assoc 2005, 293(7):843-849.
38. New M.I., Tong Y.K., Yuen T., et al. Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin Endocrinol Metab 2014, 99(6):E1022-E1030.
39. Fan H.C., Blumenfeld Y.J., Chitkara U., Hudgins L., Quake S.R. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 2008, 105(42):16266-16271.
40. Chiu R.W., Chan K.C., Gao Y., et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A. 2008, 105(51):20458-20463.
41. Chu T., Bunce K., Hogge W.A., Peters D.G. Statistical model for whole genome sequencing and its application to minimally invasive diagnosis of fetal genetic disease. Bioinformatics 2009, 25(10):1244-1250.
42. Ehrich M., Deciu C., Zweifellhofer T., et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011, 204(3). 205.e201-211.
43. Palomaki G.E., Kloza E.M., Lambert-Messerlian G.M., et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011, 13(11):913-920.
44. Bianchi D.W., Platt L.D., Goldberg J.D., et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012, 119(5):890-901.
45. Palomaki G.E., Deciu C., Kloza E.M., et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012, 14(3):296-305.
46. Porreco R.P., Garite T.J., Maurel K., et al. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol 2014, 211(4). 365.e1-12.
47. Benn P., Cuckle H., Pergament E. Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol 2013, 42(1):15-33.
48. Bianchi D.W., Parker R.L., Wentworth J., CARE Study Group, et al. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014, 370(9):799-808.
49. Sparks A.B., Wang E.T., Struble C.A., et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn 2012, 32(1):3-9.
50. Zimmermann B., Hill M., Gemelos G., et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn 2012, 32(13):1233-1241.
51. Rabinowitz M., Valenti E., Pettersen B., Sigurjonsson S., Hill M., Zimmermann B. Noninvasive aneuploidy detection by multiplexed amplification and sequencing of polymorphic Loci. Obstet Gynecol 2014, 123(suppl 1):167S.
52. Peters D., Chu T., Yatsenko S.A., et al. Noninvasive prenatal diagnosis of a fetal microdeletion syndrome. N Engl J Med 2011, 365(19):1847-1848.
53. Jensen T.J., Dzakula Z., Deciu C., van den Boom D., Ehrich M. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem 2012, 58(7):1148-1151.
54. Srinivasan A., Bianchi D.W., Huang H., Sehnert A.J., Rava R.P. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma. Am J Hum Genet 2013, 92(2):167-176.
55. Yu S.C., Jiang P., Choy K.W., et al. Noninvasive prenatal molecular karyotyping from maternal plasma. PLoS One 2013, 8(4):e60968.
56. Chu T., Yeniterzi S., Rajkovic A., et al. High resolution non-invasive detection of a fetal microdeletion using the GCREM algorithm. Prenat Diagn 2014, 34(5):469-477.
57. Rabbani B., Tekin M., Mahdieh N. The promise of whole-exome sequencing in medical genetics. J Hum Genet 2014, 59(1):5-15.
58. Costa T., Scriver C.R., Childs B. The effect of Mendelian disease on human health: a measurement. Am J Med Genet 1985, 21(2):231-242.
59. Kumar P., Radhakrishnan J., Chowdhary M.A., Giampietro P.F. Prevalence and patterns of presentation of genetic disorders in a pediatric emergency department. Mayo Clin Proc 2001, 76(8):777-783.
60. Bonnefond A., Durand E., Sand O., et al. Molecular diagnosis of neonatal diabetes mellitus using next-generation sequencing of the whole exome. PLoS One 2010, 5(10):e13630.
61. Worthey E.A., Mayer A.N., Syverson G.D., et al. Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med 2011, 13(3):255-262.
62. Talkowski M.E., Ordulu Z., Pillalamarri V., et al. Clinical diagnosis by whole-genome sequencing of a prenatal sample. N Engl J Med 2012, 367(23):2226-2232.
63. Carss K.J., Hillman S.C., Parthiban V., et al. Exome sequencing improves genetic diagnosis of structural fetal abnormalities revealed by ultrasound. Hum Mol Genet 2014, 23(12):3269-3277.
64. Hallam S., Nelson H., Greger V., et al. Validation for clinical use of, and initial clinical experience with, a novel approach to population-based carrier screening using high-throughput, next-generation DNA sequencing. J Mol Diagn 2014, 16(2):180-189.
65. Bell C.J., Dinwiddie D.L., Miller N.A., et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 2011, 3(65). 65ra4.